Holen Sie sich die Stockscreener-App
11.68
3.36%
0.38
Finanzdaten der Stoke Therapeutics Inc-Aktie (STOK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
50.46%
4.216
|
2.802 | 3.308 | -2.481 | 5.152 |
Operating Expenses
|
0.62%
32.59
|
32.39 | 30.54 | 30.78 | 29.84 |
| Benefits Costs and Expenses |
2.79%
30.59
|
29.76 | - | - | 27.70 |
| Costs And Expenses |
2.79%
30.59
|
29.76 | 30.54 | 30.78 | 27.70 |
| Operating Income/Loss |
4.10%
-28.37
|
-29.59 | -27.23 | -33.26 | -24.69 |
| Nonoperating Income/Loss |
23.97%
1.998
|
2.628 | 2.692 | 2.608 | 2.145 |
| Income/Loss From Continuing Operations Before Tax |
2.17%
-26.37
|
-26.96 | 3.308 | -30.65 | -22.55 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
2.17%
-26.37
|
-26.96 | -24.54 | -30.65 | -22.55 |
|
Net Income/Loss
|
2.17%
-26.37
|
-26.96 | -24.54 | -30.65 | -22.55 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
14,135%
46.25
|
0.3249 | 44.27 | 44.19 | 42.54 |
| Diluted Average Shares |
14,135%
46.25
|
0.3249 | 44.27 | 44.19 | 42.54 |
| Basic Earnings Per Share |
5.00%
-0.57
|
-0.60 | -0.55 | -0.69 | -0.53 |
| Diluted Earnings Per Share |
5.00%
-0.57
|
-0.60 | -0.55 | -0.69 | -0.53 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):